An Outstanding Exemplar of Driving Global Health and Social Well-Being Through Long-Term Investment in Scientific Research and Public Welfare
February 2026 · San Francisco
The International Charity and Social Organization (ICSO) officially announced that the Denmark-based Novo Nordisk Foundation has been honored with the 2026 “Global Philanthropic Model Institution” title. As one of the major international accolades established by ICSO in the global philanthropic sector, the award aims to recognize institutional funders and charitable organizations that continuously commit resources to create long-term social value across public health, scientific advancement, and societal well-being.
Following months of rigorous review and multi-dimensional evaluation by an international judging committee, the Novo Nordisk Foundation was selected for this year’s award in recognition of its sustained grant-making initiatives in global medical research, public health programs, and social development, as well as its long-term strategic framework established for philanthropic governance and scientific research support systems. The committee specifically noted that, as one of the top 20 institutional funders globally recognized by Bridgespan, the Novo Nordisk Foundation has built a stable, continuous philanthropic investment mechanism through a corporate-linked foundation model. Demonstrating profound impact in advancing life science research and public health progress, its philanthropic endeavors offer not only an international vision but also an exemplary institutional model for the global philanthropic funding ecosystem.
Research-Driven Philanthropic System: Sustained Investment in Frontier Life Sciences
The Novo Nordisk Foundation has long been dedicated to advancing life sciences and medical research through systematic scientific grants. Each year, the Foundation provides substantial research funding to universities, research institutes, and scientific teams worldwide to support frontier exploration in basic medicine, public health, and biotechnology. As a charitable foundation rooted in the life science industry, the Novo Nordisk Foundation views global public health as a core component of its philanthropic strategy. The Foundation consistently funds various projects in chronic disease prevention and control as well as healthcare system improvement, providing extensive support particularly in the fields of diabetes, obesity, and related metabolic disorders.
The judging committee observed that the Foundation’s “long-term commitment + strategic funding” model in scientific philanthropy creates a stable, continuous resource environment for scientific innovation. By establishing major scientific research funds, research fellowships, and transnational collaboration programs, the Foundation continuously accelerates the translation of basic research into clinical applications while fostering synergy across international research networks. This science-centered philanthropic practice allows research outcomes to serve public health needs more swiftly, enabling corporate-linked foundations to play a key catalytic role in the global medical research ecosystem.
Scientific Talent Development Strategy: Building a Future-Oriented Global Academic Ecosystem
Parallel to promoting scientific research, the Novo Nordisk Foundation attaches high importance to cultivating young scientific talent. The Foundation has established numerous scholarship programs, postdoctoral research fellowships, and international academic exchange initiatives to support the next generation of scientists conducting research in life sciences, medicine, and public health. These programs not only foster academic innovation but also nurture closer collaborative networks among researchers from different countries, enabling knowledge and technology to transcend geographical boundaries and generate broader societal impact.
The long-term value of scientific philanthropy is reflected not only in financial investment but also in the establishment of talent cultivation systems. Through its systematic talent development mechanisms, the Novo Nordisk Foundation provides a continuous supply of talent for the global research community, laying a solid foundation for the future development of scientific inquiry.
Institutionalized Philanthropic Governance: An International Model for Corporate-Linked Foundations
Another major contribution of the Novo Nordisk Foundation lies in its corporate-linked foundation governance model. Through a specialized management structure and an independent philanthropic strategy, the Foundation achieves long-term synergy between corporate resources and social responsibility.
Under this model, the economic value generated by corporate commercial success is continuously channeled back into public welfare, forming a stable and sustainable source of philanthropic funding. The judging committee highlighted that this governance structure not only guarantees the longevity of philanthropic investments but also allows the Foundation to execute social grant programs in a more professional and strategic manner. As a prominent representative of global institutional funders, the Novo Nordisk Foundation’s exploration of philanthropic governance provides a benchmark practice for how corporations can participate in social development through foundation models.
Committee Statement: An International Benchmark in Shaping Long-Term Social Value Through Scientific Philanthropy
In its award commendation, the ICSO Judging Committee stated: “Through sustained scientific research grants, public health initiatives, and talent development programs, the Novo Nordisk Foundation has constructed a philanthropic system with a long-term strategic vision. The institutional funder model it represents establishes a stable and profound connection between scientific research and social well-being.” This honor serves as both a high recognition of the Novo Nordisk Foundation’s continuous philanthropic commitment over the years and a testament to the crucial role it plays in the global philanthropic ecosystem.
Looking ahead, ICSO looks forward to partnering with more institutional funders like the Novo Nordisk Foundation to jointly explore tighter synergies between scientific innovation and social development. By bringing together corporate strength, academic resources, and social participation, global philanthropic endeavors will generate even more profound public value in public health, scientific research, and societal well-being.